Good day, everyone, and welcome to the Olin Corporation's Second Quarter 2017 Earnings Conference Call. All participants will be in a listen-only mode. After today's presentation, there will be an opportunity to ask questions. And please also note that this event is being recorded. I would now like to turn the conference over to Larry Kromidas, Director of Investor Relations. Please go ahead.

Thank you, William. Good morning, everyone. Before we begin this morning, I want to remind everyone that this presentation, along with the associated slides and the question-and-answer session following our prepared remarks will include statements regarding estimates of future performance. Please note that these are forward-looking statements, and that actual results could differ materially from those projected. Some of the factors that could cause actual results to differ are described without limitations in our Risk Factors section of the most recent Form 10-K and our second-quarter earnings press release. A copy of today's transcript and slides will be available on our website in the Investors section under Calendar of Events. The earnings press release and other financial data and information are available under Press Releases. With me this morning are John Fischer, Olin's Chairman, President and Chief Executive Officer; Pat Dawson, Executive Vice President and President, Epoxy and International; Jim Varilek, Executive Vice President and President, Chlor Alkali Products and Vinyls and Services; and Todd Slater, Vice President and Chief Financial Officer. Now I'd like to turn the call over to John Fischer. John?

Good morning, and thank you for joining us today. During this morning's call, we will first discuss our second-quarter results before reviewing our outlook for the second-half of the year and the key factors in earning $1 billion of adjusted EBITDA in 2017. The second-quarter adjusted EBITDA of $180.3 million fell short of expectations due to two factors. The first factor was the combined impact of the extended vinyl chloride monomer, or VCM plant turnaround and the unplanned epoxy outage. The second factor was weaker-than-expected results in the Winchester business, which experienced a second-quarter year-over-year decline in commercial ammunition sales, of approximately $21 million. Let me discuss the impact of the maintenance turnarounds and outages, a summary of which is provided on the attached slide four. This slide depicts our actual and forecasted maintenance turnaround cost, unabsorbed fixed manufacturing cost, and reduced pre-tax profits from lost sales associated with turnarounds and outages by quarter for 2016 and 2017. Maintenance turnaround work for the Gulf Coast facilities is typically performed in the first half of each year, in order to avoid the heat of the summer and the hurricane season, which maximizes the productivity and the efficiency of these turnarounds. At the integrated and major pipeline sites, we also coordinate with our customers' requirements. The first half of 2017 had a high level of planned turnaround activity, including three significant turnarounds that are performed once every three to five years. During the first quarter, the entire Plaquemine, Louisiana chlor alkali facility underwent a once-in-every-five-year turnaround, which was coordinated with our large on-site customer. During the second quarter of 2017, there were two major planned maintenance turnarounds at our largest facility in Freeport, Texas. As a result, the majority of our Freeport chlor alkali assets were offline for approximately 30 days. This…

Thanks, John. Let's turn to our 2017 cash flow forecast which is on slide 11. We expect to generate $500 million of free cash flow before dividend payments and before the $209-million ethylene investment that we expect to make soon. Our expectation is that by the end of 2017, the combination of debt reduction and EBITDA growth will reduce the net debt to EBITDA leverage ratio to the range of 3.1 times to 3.3 times. Starting with the midpoint of our full-year adjusted EBITDA forecast of $1 billion on the far left of the waterfall chart, we add back $10 million in taxes reflecting the proceeds from an income tax refund in 2017. In 2017, we continue to believe that the book effective tax rate will be in the 25% to 30% range, and we do not expect to be a cash tax payer in 2017. This reflects the utilization of net operating loss carryforwards created over the last two years. We expect net operating loss carryforwards to provide a cash tax shield of approximately $70 million in 2017. Additionally, we currently expect to exit 2017 with unused operating loss carryforwards to provide a cash tax shield in the future years of approximately $60 million to $70 million. Column three shows capital spending we expect to make in 2017. The $325 million is the midpoint of our current forecast for capital spending, with annual maintenance capital spending of between $225 million and $275 million. Last year, Olin had entered into a program to accelerate the collection of receivables which create a permanent working capital reduction of $126 million in 2016. We expect to expand this program in 2017 and realize an additional $50 million reduction in receivables. This, when combined with an inventory reduction at Winchester, will generate $75 million of cash flow from working capital reductions in 2017. The next column, one-time items include integration and cash restructuring costs of approximately $50 million. This is consistent with our prior forecast. The next column reflects an estimate of interest expense. We have approximately 30% of our debt at variable interest rates, and we're forecasting 2017 interest rates will be higher than those we experienced in 2016. On the far right column, we are forecasting $159 million of free cash flow after paying our normal quarterly dividends totaling $132 million for the year and the $209-million investment for 20 years of additional ethylene at producer economics. Finally, last Thursday, July 27, Olin's board of directors declared a dividend of $0.20 on each share of Olin common stock. The dividend is payable on September 11, 2017 to shareholders of record at the close of business on August 10, 2017. This is the 363rd consecutive quarterly dividend to be paid by the company. Operator, we are now ready to take questions.

Thank you. And at this time, we will pause for a moment to assemble our roster. And the first questioner today will be Frank Mitsch with Wells Fargo. Please go ahead.

Guys, it's Aziza on for Frank.

Good morning.

Hi. Good morning. First question, can you guys explain the change in your 2017 EDC pricing outlook? It looks like you guys were previously guiding to a 25% year-over-year increase in pricing compared to today's 20% year-over-year increase.

Yeah, this is Jim Varilek. Yeah, over the last month or so, with the success that's taking place in the caustic market, there's been more incremental players that come on with EDC into the market trying to get at the caustic. So that's caused us to lower a little bit, our forecast, year-over-year, but we're still showing a 20% increase that we're estimating for EDC prices of 2016 – 2017 over 2016.

Okay. Thanks. And within your current outlook, what are you guys assuming for the actual price realizations of the caustic price increases you guys have in place?

What we said was that we were basing our outlook on what we've seen in terms of the July change in the price indices and our expectation of what we're going to see in August and September.

Okay. Thanks, guys.

And the next questioner today is going to be Aleksey Yefremov with Nomura Instinet. Please go ahead.

Good morning, everyone and thank you. Could you describe your exposure to EDC prices? Do you have exposure to spot or contract? Are there lags? And also, do you think your real EDC pricing is more or less volatile than the spot market?

I would say, generally, the EDC realization by Olin is less volatile than the spot market and I would say we try to keep a balanced mix between contracts and spots exposure.

Thank you. You talked about 8% increase sequentially in your realized caustic soda price in the second quarter. Does this reflect any of the actual second quarter index increase, or are those still to come in the third quarter with a lag? And I guess related to that, do you expect to see higher or lower sequential increase in caustic soda in the third quarter compared to second?

I would say that what you saw in the second quarter does not reflect anything you saw in the second quarter price indices. So those are still to come. I would just say sequentially, we believe we will see better pricing on caustic soda in the third quarter than the second, and in the fourth quarter than the third.

Thank you very much.

And the next questioner today is going to be Jason Freuchtel with SunTrust. Please go ahead.

Hey. Good morning.

Good morning, Jason. How are you?

Doing great. Just following up on EDC. Is your view on EDC pricing impacted by the force majeure that Formosa declared on PVC resins, and if so, do you have a view on when that dynamic could stop weighing on EDC pricing? And then I guess also with the lower pricing, does that have an impact on how you look at the business long-term?

This is Jim Varilek. What I would say is that the short-term impact of the Formosa force majeure is not factored into EDC forecasts or pricing. And other than that, the dynamics that I mentioned earlier are intact, and we are seeing the price declines in the third quarter. And we would expect to see volatility in EDC that we normally see, and oftentimes it bounces back in the fourth quarter. And year-over-year, we're looking at that 20% increase.

Okay. Great. And can you provide some clarity on your ethylene contract with Dow? Will you receive the benefit as soon as the plan has started, or are there nuances like Dow needs to ship commercially before you receive the benefit? And I guess with that, how do you interpret Dow's use of the word imminent? Does that mean sometime in the next month?

I'm not sure how Dow interprets the word imminent. I would say we just said we expect to receive the second tranche of ethylene sometime in the third quarter, and our full-year outlook reflects that.

Okay. And then lastly, I think you've indicated in the past that the Winchester segment should be able to generate about $125 million in EBITDA. Do you still believe that in the long term the fundamental dynamics of the Winchester business will be able to support $125 million EBITDA bogey?

Yes, we do. I think we are – I believe we've experienced the worst that we're going to experience in Winchester in the first two quarters of this year and I think what you'll see is a run rate in the second half that would support $125 million a year of EBITDA.

Okay. Great. Thank you.

And our next questioner today is Don Carson with Susquehanna. Please go ahead.

John, I just wanted to clarify what's in your guidance in costs. You talked about higher pricing in Q3 and Q4. I think IHS has a $30 increase in the index in Q3 versus the $50 increase in Q2. Is that the magnitude that you have in your guidance? And does your guidance include a further increase in the index in Q4, or would that be upside to your guidance?

A further increase in the upside in Q4 is upside to our guidance. Our guidance reflects the $30 that you discussed. The – IHS is showing I think $15, $10 and $5, and that's what we based our guidance on.

Okay. And then, what success have you been having, you know, as contracts come up for renewal; have you been able to have much success in reducing the discounts off the contract price as well as the lag in terms of realizing those index price increases? And, you know, can you be ultimately specific on how you see that unfolding?

Don, this is Jim Varilek. We have had success with our contracts in a number of different ways whether they be removal of discounts, lowering of discounts, or just resetting of our, sort of, parameters. So do – we are making progress as each contract comes up and we look specifically at areas where we can improve those contracts. And our contracts run in two to five year ranges, so we'll continue to be able to upgrade those contracts as they come due over the next couple years.

Thank you.

And our next questioner today is Arun Viswanathan with RBC Capital Markets. Please go ahead.

Great. Thanks. Good morning. Just had some more questions on the guidance. So in I guess the prior calls you'd said that you were tracking at the higher end. Are you still tracking at that level? And if not, what would you attribute that to? Would it be weakness in epoxies on the raw side, or weaker volumes in Winchester, or something else in Chlor Alkali?

I think the biggest difference between how we view our full-year guidance today and where we viewed it 90 days ago when we last spoke was the impact of the unplanned outages in the second quarter. The extra $45 million to $50 million that we incurred to complete the planned outage and to remediate the unplanned outage.

Okay. That's helpful. And then similarly, on the caustic price, you had some issues with export pricing earlier in the year. Have those cleared up? And do you expect further announcements later in Q3 that would help for Q4?

I think it was second quarter of last year that we had some problems with export prices. I think if you look, export prices year-over-year are actually up more than they are in the domestic market and we're at a point where they're very close to parity.

Right. And then just lastly on Winchester. Overall, it does look like volumes have come in a little bit, and you'd have to have a pretty decent ramp to get to that 125 run rate for the full year. What gives you confidence in that assumption and what are some good metrics that you're going to be tracking to make sure that's on par with your expectations? Thanks.

As we said in the remarks, most of our big customers during the first half of the year were selling more than they were buying. And that's not sustainable long term. Second, we do – this is the strongest seasonal period for the business, Q3, and we've had years where 35%, 40% of our revenue occurs in Q3. And we've also said that we've got a better outlook for military business. And that really, the biggest impact on that is in the second half, not in the first half and that impact will also carry us through most of next year in terms of the military. So I'd say there's really three or four factors that give us confidence there.

Okay. Great. Thanks. And if I may, just one more quickly on the synergies; any change to your outlook on how those are impacting your EBITDA? And if you have any update on revenue synergies as well, that would be helpful. Thanks.

There's no change in our outlook in synergies. The biggest revenue synergy that we talked about, the growth, 15% year-over-year growth, in the bleach business. That is really the largest revenue synergy that we have going on right now.

Thanks.

And the next questioner today is going to be Josh Spector with UBS. Please go ahead.

Hey, guys. Just a question on caustic soda volumes for the second quarter. In slide 16, you show volumes down year-over-year and quarter-over-quarter. On chlorine, you show as up quarter-over-quarter and flat year-over-year. Can you help explain the difference in dynamic? Is it the external versus the internal sales, or is there something else going on? Because I would imagine the maintenance turn-around impacted both.

The maintenance, the chlorine business is primarily the merchant business. And the merchant business was not really affected by the outages. Those outages were more around the internal and other products where the chlorine goes such as VCM and Epoxy. So the merchant chlorine business was generally unaffected. The unplanned outages did affect the amount of caustic soda we had available because we weren't running chlorine for the vinyls piece, we weren't running chlorine for the epoxy piece, and so that's sort of the mix. We have quite a – as you know, just from our sensitivities, we have quite a bit more caustic soda to sell in any quarter than we do chlorine – that we sell as chlorine.

Okay. That makes sense. Thanks. And just on Epoxy real quick, the volume growth that you noted, I believe you said about 5%, can you tell us whether that was more upstream or downstream products?

Yeah, this is Pat Dawson. It was more centered around the upstream and also Europe continues to grow nicely as well, on the mid-stream, so those were the two primary areas.

Okay. Great. Thanks, guys.

And the next questioner today is going to be Dmitry Silversteyn with Longbow Research. Please go ahead.

I think you mentioned it, but I missed it. What was your chlorine price increase in the second quarter versus the first quarter?

We said that the prices, sequentially, were similar, that the second quarter was up 5% year-over-year.

Okay. 5% year-over-year and flattish sequentially. Got it. Secondly, just turning to your Epoxy segment, I mean, you've been raising pricing there pretty aggressively, obviously the EBIT line loss expanded in the second quarter having to do with this – with the bisphenol-A outage probably. How should we think about the profitability on that business in the second-half of the year? You know, you talk about a little bit of easing on the raw material front, hopefully, you'll get a little bit more traction. Should we be looking forward to a positive EBIT contribution from this business in the second half of the year?

Yes, you should and I would take you back to the comment we made, which is, we believe that the combination of the price increases and the higher hydrocarbon costs in the third quarter will allow the business to return to the margins you saw in the third quarter of last year.

And that's (35:20) kind of the overall demand environment for Epoxies. Can you sustain these prices in – when raw materials start rolling over? Is there enough demand to cause a little bit of a snugness in the market, or do you expect to give out these pricing pretty quickly as benzene and propylene come down?

Yeah, again, this is Pat Dawson. I would tell you that in the month of June, we saw prices stable. We think the demand is starting to show some modest improvements in North America. You got to remember last year North America had actually contracted, mainly due to oil and gas, so we're starting to see improvements there. Europe continues to grow very nicely, and we think most of the bottom out in Asia Pacific has been seen and starting to see some improvements in demand there as well.

And then just final question on the caustic volume decline in the second quarter year over year, I'm looking at about 5% according to my model. Am I in the ballpark?

We haven't really commented on a specific amount, Dimitry.

Okay. Thank you.

And our next questioner today is Matthew Blair with Tudor, Pickering, Holt. Please go ahead. Matthew Blair - Tudor, Pickering, Holt & Co. Securities, Inc.: Hey, good morning, guys.

Good morning. Matthew Blair - Tudor, Pickering, Holt & Co. Securities, Inc.: I was hoping you could talk about your deleveraging outlook. I think your debt to EBITDA is currently just above four. Your long-term target is in that one-and-a-half to two times range. Are you planning to reduce debt solely through free cash flow or asset sales or possible Winchester spin on the table here? Thanks.

We would expect, by the end of this year, with the improvement of EBITDA to be in that 3.1 to 3.3 net debt to EBITDA range, and as we move into 2018 and beyond, we expect to use excess cash flow from the business to de-lever. Matthew Blair - Tudor, Pickering, Holt & Co. Securities, Inc.: Okay. Great. And then on the Winchester margins coming in around 14%, can you split out how much was due to raw material pressures and how much was due to pricing pressures here?

I would answer that with a third comment. The majority of it was due to reduced sales volumes and an unfavorable product mix. Matthew Blair - Tudor, Pickering, Holt & Co. Securities, Inc.: Okay. Sounds good. Thanks.

And the next questioner today is going to be Stephen Byrne with Bank of America-Merrill Lynch. Please go ahead.

Thanks. This is Ian (37:57) on for Steve. Thanks for those slides on the maintenance and turnaround costs. Would you use 2016 as a normal year for maintenance and turnaround spending, or do you have sufficient history with these assets to be able to forecast what a kind of underlying economic rate of turnaround and maintenance costs are?

Based on what we know right now, I would tell you that 2016 would be at the low end of what we would expect and 2017 would be at the high end of what we would expect. It'll be lumpy but I think those two probably bracket what we expect to see.

Okay. And then for the-approximately half of your caustic that's produced that is turned into derivatives, how does the price of those derivatives compare to the change in price of caustic soda you mentioned earlier, of 8% sequentially and 36% year over year?

I guess I'm confused by the question. Very little of our caustic soda is converted to anything. The majority of what we make is all sold. Some of its sold to our pipeline customers, the rest of it sold to the market. The question may be, how much of our chlorine that we produce which goes into derivatives but maybe you can clarify for me what you mean.

Yes, I was under the impression that some of the caustic is turned into other derivatives that are not sold like specifically to the market, but maybe I'm mistaken.

The only place that we use significant amounts of caustic is in the manufacture of bleach, which is chlorine and caustic together. That's a relatively small percentage of our business. I would tell you, however, that bleach pricing does reflect the underlying market price of chlorine and caustic soda.

Thank you very much.

And the next question here today is going to be Kevin McCarthy with the Vertical Research Partners. Please go ahead.

Yes, good morning. Apologies if I missed it, but would you comment on the amount of chlorine price that you achieved versus your proposal in the third – sorry, yeah, I guess basically the month of July, kind of entering the third quarter here. What's your view of chlorine?

What we said was that the first and second-quarter merchant chlorine prices were similar to each other and that we expected chlorine to improve sequentially in Q3 versus Q2 and then again in Q4 versus Q3.

Okay. Thank you for that. And then just coming back to the outages and following up on Ian's (40:52) question, would you care to hazard a preliminary guess as to the likely impact of your planned maintenance in 2018, versus the $209 million aggregate that you show on slide four for 2017? <: We said that 2018 would be meaningfully lower than 2017.

Okay. We'll stay tuned on that. And then I guess one small one to wrap up. You took about $4.4 million in acquisition-related costs in the quarter; what is the nature of those that are kind of still hanging around at this point, and when would you expect those to roll out of the financials?

This is Todd. We had estimated at the beginning of the year, that between restructuring and acquisition integration costs, that would be about $50 million and I think we're still on track for that to be the expense for the full year.

Okay. Thank you.

And our next questioner is going to be a follow-up from Jason Freuchtel with SunTrust. Please go ahead.

Hi. Thanks for taking my follow-up. This is more of a strategic question, but do you believe producers will need to spend more on maintenance costs more frequently for either planned or unplanned outages than they have in the past, several years and a higher operating environment? And with that, do you expect younger assets like your assets in Freeport, Texas will be advantaged relative to other industry assets in a higher operating rate environment?

I would agree with your basic premise that high operating rates are going to lead to more frequent maintenance turnarounds, and I would just offer that not only do we have newer assets in Freeport, our plant in Saint Gabriel is less than 10 years old, our plant in Charleston is less than 10 years old. So I think across the Olin system, we have relatively young assets versus the industry.

Okay. Thank you.

And the next question is a follow-up from Stephen Byrne with Bank of America-Merrill Lynch. Please go ahead.

Again, thanks for letting me get in the queue with a follow-up. Just on the outlook for the full-year, $1 billion EBITDA, what do expect the cadence of that to be for the 3Q and 4Q?

I think if you look at 2016, which is the only real marker we have for the new business, the third and fourth quarters were very similar.

Thank you very much.

There looks to be no further questions, so this will conclude the question-and-answer session. I would like to turn the conference back over to John Fischer for his closing remarks.

Thank you all for joining us today, and we look forward to speaking with you about our third quarter in about 90 days. Thank you.

The conference has now concluded. Thank you all for attending today's presentation, you may now disconnect your lines.